前田裕弘

前田 裕弘（まえだ やすひろ、1955年3月9日 - ）は日本の医師。専門は血液内科、免疫内科。日本血液学会 血液専門医・指導医、日本エイズ学会 指導医、日本臨床免疫学会 免疫療法認定医。最終学歴は近畿大学。

 来歴 
大阪府河内長野市生まれ。医学博士。1980年3月近畿大学医学部卒、同年6月同大学医学部第三内科学教室入局。同教室の講師に。その後、米国に渡りワシントン大学医学部病理学教室入局。日本に戻り近畿大学医学部の助教授を経て教授に。血液病理学、移植学、がん薬物療法、エイズ、免疫療法学に研鑽、現場に従事。

 経歴 

1980年3月　近畿大学医学部卒業
1980年6月　近畿大学医学部第三内科学教室入局
1982年4月　同教室助手
1987年4月　京都大学医学部免疫研究施設Ｉ
1989年4月　近畿大学医学部第三内科学教室講師
1990年4月　米国ワシントン大学医学部病理学教室（ｾﾝﾄﾙｲｽ）
2002年4月　近畿大学医学部血液・腎臓・膠原病内科助教授
2008年10月　近畿大学医学部教授
2011年4月　近畿大学医学部客員教授
2011年4月　国立病院機構大阪南医療センター　がん疾患センター部長
2016年4月　国立病院機構大阪南医療センター特命副院長併任
2020年4月　医療法人浩仁会南堺病院　病院長
2021年8月　医療法人敬任会南河内おか病院　副院長
2023年6月　医療法人社団日翔会まえだクリニック　院長

 所属学会 
日本血液学会　血液専門医・指導医
日本臨床血液学会　評議員
日本臨床腫瘍学会　暫定指導医
日本移植学会　認定医
日本エイズ学会　認定医・指導医
日本臨床免疫学会　免疫療法認定医
日本感染症学会　インフェクションコントロールドクター
日本再生医療学会　評議員
日本HTLVーI学会　評議員
日本癌学会
日本内科学会
欧州血液学会　
米国血液学会
国際実験血液学会

 研究者 
日本の研究.com  研究者ID : 231197
KAKEN　研究者番号 :  10173717
J-GLOBAL ID：200901031844131608

 論文 
Akinobu Tojo, Yasuhiro Maeda, et al.「A phase I/II study of nilotinib in Japanese patients with imatinib-resistant or-intolerant Ph+ CML or relapsed/refractory Ph+ ALL.」『International Journal of Hematology』. 89:679-688, 2009 A phase I/II study of nilotinib in Japanese patients with imatinib-resistant or-intolerant Ph+ CML or relapsed/refractory Ph+ ALL.　Int J Hematol. 89:679-688, 2009
Ohyashiki K, Maeda Y, et al.「Increased natural killer cells and decreased CD3(+) CD8(+) CD62L(+) T cells in CML patients who sustained complete molecular remission after discontinuation of imatinib.」『	British J Haematology』157:254-256, 2012 Increased natural killer cells and decreased CD3(+) CD8(+) CD62L(+) T cells in CML patients who sustained complete molecular remission after discontinuation of imatinib.　British J Haematology 157:254-256, 2012
Kensuke Usuki, Yasuhiro Maeda, et al.「Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL: a 36-month analysis of a phase I and II study.」『International journal of hematology』95:409-19, 2012
Kazunori Ohnishi, Yasuhiro Maeda, et al.「Long-term outcome following imatinib therapy for chronic myelogenous leukemia, with assessment of dosage and blood levels: the JALSG CML202 study.」『Cancer Science』103: 1071-1078, 2012
Yasuhiro Maeda, et al.「Improved drug adherence in patients with chronic myeloid leukemia in chronic phase by switching to second-generation tyrosin kinase inhibitors.」『Acta Haematologica』138 (3):140-142, 2017
Shin Fujisawa, Yasuhiro Maeda, et al.「Feasibility of the imatinib stop study in the Japanese clinical setting: delightedly overcome CML expert stop TKI trial (DOMEST Trial).」『International Journal of Clinical Oncology』2019 Apr; 24(4):445-453.
Yasuhiro Maeda, et al.「Clinical Importance of Drug Adherence during Tyrosine Kinase Inhibitor Therapy for Chronic Myelogenous Leukemia in Chronic Phase.」『Reports 2019』2, 25; doi:10.3390/reports2040025
Yasuhiro Maeda, et al.「Investigation about down-regulation of CD3 antigen on adult T cell leukemia cells. Flow Cytometry and Image Analysis for Clinical Applications.」『Elsevier Science Publishers B.V.』1991, p247-252
Mitsuhiro Matsuda, Yasuhiro Maeda, et al.「CD3 down-regulating factor in sera and culture supernatants of leukemic cells from the patients with adult T cell leukemia.」『British J. Haematol.』83: 212-217, 1993
Mitsuhiro Matsuda, Yasuhiro Maeda, et al.「Possible involvement of protein kinase C activation in down-regulation of CD3 antigen on adult T cell leukemia cells.」『British Journal of Haematology』86: 399-401, 1994
Yasuhiro Maeda, et al.「The down-regulation of CD3 antigen on Adult T cell Leukemia cells.」『Leukemia and Lymphoma』13: 249-256, 1994
Yasuhiro Maeda, et al.「13-cis retinoic acid Inhibits growth of adult T cell leukemia cells and causes apoptosis ; possible new indicator for retinoid therapy.」『Internal Medicine』35: 180-184, 1996
Yasuhiro Maeda, et al.「New Therapeutic effects of retinoid for adult T cell leukemia.」『BLOOD』88: 4726-4727, 1996
Jun-ichi Miyatake and Yasuhiro Maeda.「Retinoid induces growth inhibition of adult T-cell leukemia cells.」『Acta Medica Kinki University』22:111-121, 1997
Jun-ichi Miyatake and Yasuhiro Maeda.「Inhibition of proliferation and CD25 down-regulation by retinoic acid in human adult T cell leukemia cells.」『Leukemia』11: 401-407, 1997
Jun-ichi Miyatake, Yasuhiro Maeda, et al.「Thiol compounds rescue growth inhibition by retinoic acid on HTLV-I (+) T lymphocytes; possible mechnism of retinoic acid induced growth inhibition of adult T cell leukemia.」『Hematopathology and Molecular Hematology』11(2): 89-99, 1998
Jun-ichi Miyatake, Yasuhiro Maeda, et al.「Important role of thiol compounds to protect oxidative stress on HTLV-I(+) T lymphocytes.」『Leukemia Res』24(3): 265-266, 2000
Yasuhiro Maeda, et al.「Clinical application of all-trans retinoic acid (Tretinoin) for adult T cell leukemia.」『Br. J. Haematol』109: 677-678, 2000
Hiroyuki Nawata, Yasuhior Maeda, et al.「A mechanism of apoptosis induced by all-trans retinoic acid on adult T-cell leukemia cells: a possible involvement of the Tax/NF-kappaB signaling pathway.」『Leukemia Res』25(4): 323-331, 2001
Yasuhiro Maeda, et al.「All-trans retinoic acid reduced skin involvement of adult T-cell leukemia.」『Leukemia』18: 1159-1160, 2004
Terufumiu Yamaguchi, Yasuhiro Maeda, et al.「Dichotomy of all-trans retinoic acid inducing signals for adult T-cell leukemia.」『Leukemia』19:1010-7, 2005
Yasuhiro Maeda, et al.「Clinical efficacy of all-trans retinoic acid for treating adult T-cell leukemia.」『Journal of Cancer Reseaech of Clinical Oncology』134:673-677, 2008
Satomi Ueda, Yasuhiro Maeda, et al.「Influences of Epstein-Barr virus infection in adult T-cell leukemia.」『Hematology』13:154-162, 2008
Chikara Hirase, Yasuhiro Maeda, et al.「Hypersensitivity pf Ph-positive lymphoid cell lines tp rapamycin: Possible clinical application of mTOR inhibitor.」『Leukemia Res』33:450-459, 2009
Chikara Hirase, Yasuhiro Maeda, et al.「mTOR inhibition and adult T-cell leukemia.」『Leukemia and Lymphoma』50:645-647, 2009
Yasuhiro Maeda.「Retrovirus infection and retinoid. (Review).」『Acta Med Kinki Univ』34:1-13, 2009
Chen Z, Maeda Y, et al.「Thioredoxin-binding protein-2 (TBP-2/VDUP1/TXNIP) regulates T-cell sensitivity to glucocorticoid during HTLV-I-induced transformation.」『Leukemia』25:440-448, 2011
Yasuhiro Maeda, et al.「Senescence induction therapy for the treatment of adult T-cell leukemia.」『Leukemia and Lymphoma』52:150-152, 2011
Yasuhiro Maeda, et al.「Retrovirus infection and retinoid.」『T-cell leukemia. Edited by Olga Babusikova et al. InTECH』2011
Yasuhiro Maeda, et al.「Cellular senescence induction by retinoid on adult T-cell leukemia cells.」『Retrovirology 2011』2011, 8(Suppl 1):A31 (6 June 2011)
Yasuhiro Maeda, et al.「Effects of tamibarotene for treatment of adult T-cell leukemia.」『Ann Hematology』91:629-631，2012
Yasuyo Ohyama, Yasuhiro Maeda., et al.「Induction of molecular remission by using anti-CC-chemokine receptor 4 (anti-CCR4) antibodies for adult T-cell leukemia: a risk of opportunistic infection after treatment with anti-CCR4 antibodies.」『Ann Hematology』93:169-71, 2014
Yasuhiro Maeda, et al.「Relationship between Cellular Senescence and Redox Potential on Adult T-Cell Leukemia Cells.」『Journal of Blood Research & Hematologic Diseases』 1:1.doi:10.4172/jbrhd.1000101
Yasuhiro Maeda, et al.「Adult T-Cell Leukemia and Retinoid.」『Journal of Hematology Research』2016.3:1-5
Yasuhiro Maeda, et al.「Deleted mutation of GSTT-1 gene in patients with MDS.」『Leukemia』12(12): 2039, 1998
Mitsuhiro Matsuda, Yasuhiro Maeda, et al.「Establishment of a myelodysplastic syndrome (MDS)/ secondary AML-derived T lymphoid cell line K2-MDS.」『Leukemia Res』24:103-108, 1999
Yoshiyasu Sumimoto, Yasuhiro Maeda, et al.「Establishment of a myeloid cell line, YM711, characterized by retinoid resistance.」『Leukemia and Lymphoma』39: 373-383, 2000
Hajime Miyazato, Yasuhiro Maeda, et al.「Detection of myeloperoxidase gene expression by in situ hybridization in a case of granulocytic sarcoma associated with AML-M0.」『Leukemia』16:1797-1799, 2001
Mitsuhiro Matsuda, Yasuhiro Maeda, et al.「Mitsuhiro Matsuda, Yasuhiro Maeda, et al.」『Int. J. Hematol』75: 335-336, 2002
Yasuhiro Maeda, et al.「Mutant type of glutathione S-transferase theta 1 gene homologue to mTOR in myelodysplastic syndrome :possible clinical application od rapamycin.」『Leukemia and Lymphoma』44: 1179-1185, 2003
Mitsuhiro Matsuda, Yasuhiro Maeda, et al.「CD34+ progenitors from MDS patients are unresponsive to SDF-1, despite high levels of SDF-1 in bone marrow plasma.」『	Leukemia』18: 1038-1040, 2004
Yasuyoshi Morita, Yasuhiro Maeda, et al.「A perforin/granzyme-positive MDS-derived T cell line, K2-MDS, induces apoptosis in CD34(+) cells through the fractalkine-CX3CR1 system.」『Clin Immunol』113:109-116, 2004
Mitsuhiro Matsuda, Yasuhiro Maeda, et al.「Extramedullary blast crisis derived from 2 different clones in the central nervous system and neck during complete cytogenetic remission of chronic myelogenous leukemia treated with Imatinib mesylate.」『International Journal of Hematology』81: 307-309, 2005
Yasuhiro Maeda, et al.「Possible molecular target therapy with rapamycin in MDS.」『Leukemia and Lymphoma』47: 907-911, 2006
Yasuhiro Maeda, et al.「Relationship between expression of mutant type glutathione S-transferase theta-1 gene and reactivity of rapamycin in myelodysplastic syndrome.」『Hematology』14:266-270, 2009
Yasuyoshi Morita, Yasuhiro Maeda, et al.「A case of chronic myelomonocytic leukemia who developed pericardial effusion during stably controlled leukocytosis.」『Internal Medicine』50:1737-1740, 2011　Retrovirology 8:100, 2011
Takahiro Kumode, Yasuhiro Maeda et al.「A case of secondary leukemia subsequent to myelodysplastic syndromes successfully treated with azacitidine.」『Case Reports in Medicine』Volume 2014, Article ID 793928, 3 pages
Yasuhiro Maeda, et al.「Transient eosinophilia by HIV infection.」『Ann. Hematol』79(2): 99-101, 2000
Yasuhiro Maeda, et al.「Herbs for HIV infection.」『Am J Hematol』70:263-264, 2002
Yasuhiro Maeda, et al.「All-trans retinoic acid attacks reverse transcriptase resulting in inhibition of HIV-1 replication.」『Hematology』12:263-266, 2007
Atsushi Sasakawa, Yasuhiro Maeda, et al.「Interleukin-8 in the pathogenesis of primary central nervous system lymphoma in association with HIV infection.」『Hematology』17:144-150, 2012
前田裕弘「ステロイド投与中の高脂血症の治療」『診療と新薬』61：15-18, 2024
CiNii収録論文 - CiNii
https://cir.nii.ac.jp/articles?q=%E5%89%8D%E7%94%B0%E8%A3%95%E5%BC%98

 著書 
『血液疾患における多職種の関わり : ５つの症例から考えるチーム医療の実際』中外医学社、2020年4月7日。
『ウィルスとインターフェロン』慢性肝炎のインターフェロン療法(日本医学館) 1993年。
『Investigation about down-regulation of CD3 antigen on adult T cell leukemia cells』Flow cytometry and Image analysis for Clinical Application Elsevier Science Publisher 1991
『Signal transduction through FcεR2/Cd23 ; Induction of IL-2R/p55(Tac) by stimulation of Fc R2/Cd23』Luekocyte Typing Oxford University Press

 脚注 
 出典 

Category:1955年生
Category:存命人物
Category:河内長野市出身の人物
Category:近畿大学出身の人物
Category:日本の医師